Yazici, O.Unsal, O.Ozdemir, N.Uner, A.Ozet, A.2024-06-262024-06-262021-09-210923-7534https://doi.org/10.1016/j.annonc.2021.08.1561https://hdl.handle.net/11452/42459Bu çalışma, 16-21 Eylül 2021 tarihleri arasında düzenlenen Congress of the European-Society-for-Medical-Oncology (ESMO)’da bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessScience & technologyLife sciences & biomedicineOncologyOncologyClinical and laboratory outcomes of solid cancer patients reinfected with sars-cov-2Meeting Abstract000700527703114S1133S113432Supplement 510.1016/j.annonc.2021.08.1561